- Home
- OPAL vs ANVS Comparison
OPAL vs ANVS Comparison
Compare OPAL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPAL | ANVS |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.3M | 111.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | OPAL | ANVS |
|---|---|---|
| Price | $2.59 | $3.51 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $2.81 | ★ $13.50 |
| AVG Volume (30 Days) | 266.2K | ★ 847.8K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $329,243,000.00 | N/A |
| Revenue This Year | $17.15 | N/A |
| Revenue Next Year | $22.04 | N/A |
| P/E Ratio | $118.91 | ★ N/A |
| Revenue Growth | ★ 7.26 | N/A |
| 52 Week Low | $1.26 | $1.11 |
| 52 Week High | $4.08 | $5.60 |
Technical Indicators
Market Signals| Indicator | OPAL | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 45.93 |
| Support Level | $2.00 | $3.49 |
| Resistance Level | $2.73 | $3.72 |
| Average True Range (ATR) | 0.20 | 0.34 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 67.82 | 4.24 |
Price Performance
Historical ComparisonAbout OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.